David is the visionary Founder and CEO of Remitz, a trailblazer in automated revenue recovery services within the healthcare industry. Under his leadership, Remitz has emerged as a key player, redefining medical billing through innovative, data-driven analytics and groundbreaking technologies. Remitz stands as a testament to David's commitment to "Collecting the Uncollectible: Medical Billing Made Easy," backed by a team of experts and cutting-edge deep learning algorithms.Concurrently, as the CEO of Medivolve, David was instrumental in orchestrating a monumental response to the COVID-19 pandemic. Under his leadership, Medivolve achieved a significant milestone, administering COVID tests valued at over $100 million, a testament to the company's pivotal role during this global health crisis. Spearheading operations across 45+ clinical testing sites, David efficiently managed a robust team of over 400 clinical staff members.Prior to his current roles, David focused his efforts leading Xenomics. There, he led a team of PhDs in creating a full-stack biotechnology platform, integrating disruptive gene-editing technology, optofluidic liquid handling chips, and atomic-level resolution analytics, all unified by robust computing power.David's foundational training in biotechnology stems from Harvard University (Extension School), where he was a BLA candidate in Biology, with additional training in Engineering Science and Nanotechnology. He has a record of academic excellence, having been the Microsoft Prize Winner at Hack Harvard in 2015, Intel Prize Winner at Stanford TreeHacks in 2016, and a 3rd Place Winner at Yale Hack Health in 2016. Before returning to academia, David led a 160-person startup (expanding to over 700 including consulting clientele) and co-founded three other profitable ventures.At Biotii Technologies, David spearheaded a team of PhDs to innovate in biosynthesizing cannabigerolic acid from d-glucose using genetically modified yeast.David's humanitarian spirit is equally notable. In the aftermath of the 2010 Haitian earthquake, he was instrumental in delivering over 40,000 bottles of water to survivors and collaborated with local NGOs to rebuild approximately 15 schools across Haiti through Fondation Appui A L’Éducation. His early career included time as a clinical technician in the Neurology Department at Boston Children's Hospital, concurrent with his studies at Harvard.